Quantifying the Predictive Power of Social Determinants of Health in Cardiovascular Disease and Type 2 Diabetes Progression Using XGBoost: Retrospective Cohort Study - Report - MDSpire

Quantifying the Predictive Power of Social Determinants of Health in Cardiovascular Disease and Type 2 Diabetes Progression Using XGBoost: Retrospective Cohort Study

  • By

  • Hielke Muizelaar

  • Marcel Haas

  • Maarten van Aken

  • Rimke Vos

  • Marco Spruit

  • July 9, 2026

  • 0 min

Share

Clinical Report: Assessing the Impact of Social Determinants on CVD and DM2

Overview

This study evaluates the predictive value of social determinants of health (SDOH) in the progression of cardiovascular disease (CVD) and type 2 diabetes (DM2) using machine learning techniques.

Background

The interrelation between metabolic anomalies and social factors significantly influences the risk of developing CVD and DM2. Traditional risk prediction models often overlook these social determinants.

Data Highlights

No numerical data or trial data provided in the source material.

Key Findings

  • Metabolic syndrome is a predictor of both DM2 and CVD.
  • Traditional models often exclude social determinants of health (SDOH).
  • Machine learning models can outperform traditional statistical methods in predicting cardiovascular risk.
  • Incorporating SDOH into risk models may improve prediction accuracy.
  • Existing models like SCORE2 have been shown to underestimate CVD risk in low socioeconomic groups.

Clinical Implications

Healthcare providers should consider integrating social determinants of health into routine assessments for CVD and DM2 risk. This approach may lead to more accurate risk stratification and tailored interventions for patients from diverse backgrounds.

Conclusion

Further research is needed to validate these findings across different populations.

Related Resources & Content

  1. Frontiers in Medicine, 2026 -- An XGBoost-based model for detecting undiagnosed type 2 diabetes using routine physical and lifestyle data from a multi-center Chinese population
  2. European Journal of Preventive Cardiology, 2025 -- External Assessment of Cardiovascular Risk Assessment Models in Type 2 Diabetes Patients Utilizing the CARDIANA Cohort from Spain
  3. European Journal of Preventive Cardiology, 2025 -- Variations in the Relationship Between Modifiable Lifestyle Risk Factors and New-Onset Cardiovascular Disease in Diabetic versus Non-Diabetic Individuals
  4. European Journal of Preventive Cardiology — Cardiovascular health scores as predictors. Where to go next?
  5. ADA’s Standards of Care in Diabetes—2026
  6. Screening for Health-Related Social Needs: American College of Preventive Medicine's Practice Statement
  7. Final Recommendation Statement: Screening for Food Insecurity | United States Preventive Services Taskforce
  8. ESC 365 - Impact of neighbourhood and environmental factors on the risk of incident cardiovascular disease: a systematic review and meta-analysis
  9. The relation between socioeconomic status and societal development with cardiovascular disease - A systematic review and meta-analysis on global data - PubMed
  10. Loneliness and social isolation as risk factors for type 2 diabetes onset: A systematic review and meta-analysis - PubMed
  11. Voucher for Healthy Foods and Diabetes Control: A Randomized Clinical Trial - PubMed
  12. Enhanced cardiovascular disease risk prediction using integrated machine learning models: a study from the UK Biobank cohort | Open Heart
  13. Pragmatic Approaches to the Evaluation and Monitoring of Artificial Intelligence in Health Care - Professional Heart Daily | American Heart Association
  14. Criteria to Assess the Predictive and Clinical Utility of Novel Models, Biomarkers, & Tools for Risk of Cardiovascular Disease - Professional Heart Daily | American Heart Association

Original Source(s)

Related Content